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Abstract
Purpose To determine the ability of Saccadic Vector Optokinetic Perimetry (SVOP) to detect and characterise visual ﬁeld
defects in children with brain tumours using eye-tracking technology, as current techniques for assessment of visual ﬁelds in
young children can be subjective and lack useful detail.
Methods Case-series study of children receiving treatment and follow-up for brain tumours at the Royal Hospital for Sick
Children in Edinburgh from April 2008 to August 2013. Patients underwent SVOP testing and the results were compared
with clinically expected visual ﬁeld patterns determined by a consensus panel after review of clinical ﬁndings, neuroimaging,
and where possible other forms of visual ﬁeld assessment.
Results Sixteen patients participated in this study (mean age of 7.2 years; range 2.9–15 years; 7 male, 9 female). Twelve
children (75%) successfully performed SVOP testing. SVOP had a sensitivity of 100% and a speciﬁcity of 50% (positive
predictive value of 80% and negative predictive value of 100%). In the true positive and true negative SVOP results, the
characteristics of the SVOP plots showed agreement with the expected visual ﬁeld. Six patients were able to perform both
SVOP and Goldmann perimetry, these demonstrated similar visual ﬁelds in every case.
Conclusion SVOP is a highly sensitive test that may prove to be extremely useful for assessing the visual ﬁeld in young
children with brain tumours, as it is able to characterise the central 30° of visual ﬁeld in greater detail than previously
possible with older techniques.
Introduction
Central nervous system (CNS) tumours are the commonest
solid tumours of childhood and the most common cause of
childhood cancer death. Primary malignant brain tumours
have an age-adjusted incidence rate of 3.27/100,000 in
children aged 0–14 years at time of diagnosis. The most
frequently occurring tumours are pilocytic astrocytomas
(26%) and Primitive Neuroectodermal Tumours (PNET)
including medulloblastoma (22%). Other gliomas (e.g.
ependymoma, oligodendroglioma and choroid plexus
tumours) occur less commonly [1]. Visual pathway gliomas
account for 3–5% of all paediatric CNS tumours [2].
Current strategies for children with brain tumours aim to
maintain survival rates with minimal treatment related long-
term sequelae. Hence their management requires multi-
disciplinary team (MDT) input in treatment and monitoring
[3]. These children commonly have visual ﬁeld defects not
reported by the child nor recognised by the care-giver [4].
When tumours involve the visual pathways, preservation of
vision becomes a treatment objective. Careful ophthalmo-
logical follow-up is required in conjunction with other
MDT specialties namely; paediatric neuro-oncology, neu-
rology, neurosurgery, radiology and radiotherapy [5].
Ophthalmological assessment usually takes the form of
fundoscopy including assessment of optic disc appearances,
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along with visual acuity (VA), colour vision and visual ﬁeld
testing. Objective visual ﬁeld testing is valuable in
demonstrating stability or progression of a tumour, parti-
cularly if the tumour involves the anterior visual pathway,
and if visual ﬁeld changes are corroborated by MRI
appearances effective clinical management decisions can be
made. Visual ﬁeld information also allows practical advice
to be provided to assist a child’s daily living.
Despite the potential beneﬁts, there is a dearth of effec-
tive visual ﬁeld testing methods appropriate for children
under 5 years that can provide reliable detail greater than
that gained from the confrontation method. Confrontation in
children typically requires one examiner to gain a child’s
ﬁxation, and a second examiner to introduce dynamic sti-
muli into various part of the child’s visual ﬁeld from the rear
and side while the ﬁrst examiner observes the child’s gaze
for a reaction. The technique allows only an approximate
assessment of visual ﬁeld defects and in children its use-
fulness is limited by the attention and concentration of the
child. Obtaining reliable and objective ﬁeld testing in
healthy young children is challenging and frequently more
difﬁcult in children who are ill as a result of brain tumours.
The difﬁculties associated with performing standard auto-
mated perimetry (SAP) in children are well known. The
main problems children have with SAP are understanding
how to perform the test and maintaining central ﬁxation [6,
7]. Manual kinetic perimetry is more popular in children
between the ages of 5 and 9 years because the test can be
tailored to the child’s ability [8, 9]. However, the technique
still requires the child’s cooperation and understanding, and
results can be dependent upon the examiner’s testing skills
[10]. More recently, a modiﬁed form of arc perimetry, the
behavioral visual ﬁeld (BEFIE) test, has been assessed in a
large cohort of children [11]. BEFIE was found to be a
useful tool for detecting visual ﬁeld defects in young or
neurologically impaired children. However, the technique is
dependent on the skills of an examiner and an observer, and
is not suited to identifying absolute scotomas or relative
defects.
Saccadic Vector Optokinetic Perimetry (SVOP) is an
objective visual ﬁeld assessment technique developed spe-
ciﬁcally for young children unable to perform conventional
forms of perimetry [12, 13]. It uses a multi-ﬁxation target
strategy, in combination with modern eye-tracking tech-
nology to monitor real-time ﬁxations and eye movement
responses to visual ﬁeld stimuli. SVOP makes automated
decisions on whether or not visual ﬁeld stimuli have been
seen based on a child’s natural eye movements. The child
does not need to maintain ﬁxation on a single target, nor do
they need to make responses with a push button. Hence,
there is no great requirement for understanding the test.
SVOP continuously monitors patient position and can pre-
sent visual stimuli at speciﬁc visual ﬁeld locations even if
the patient moves during the test meaning that the child’s
head does not need to be placed on a chinrest.
The aim of this study was to determine the feasibility of
SVOP in the detection and characterisation of visual ﬁeld
defects in children with brain tumours, and to authenticate
the SVOP results by comparing them with clinically
expected visual ﬁeld patterns following review of neuroi-
maging, and where possible other forms of visual ﬁeld
assessment.
Methods
Patients
The families of children with known or suspected brain
tumours managed at the Royal Hospital for Sick Children in
Edinburgh from April 2008 to August 2013 were invited to
participate in the study.
Study method
Each patient underwent binocular SVOP visual ﬁeld testing.
In addition, monocular testing was also performed if the
patient was considered of a suitable developmental ability.
Many of the participants were tested repeatedly over months
or years of follow-up. This study reports the ﬁrst SVOP
testing episode for each child.
All patients had undergone MRI neuroimaging as part of
their oncological workup and ongoing treatment. A con-
sensus panel comprising an experienced ophthalmologist
(BF), neurologist (RM) and neuro-radiologist (GW),
reviewed the MR images for the scanning session for each
patient that was closest in time to their SVOP test date. Care
was taken to ensure that none of the patients had undergone
interventions such as radiotherapy or surgery in the interval
between the MR imaging session and the SVOP test. The
panel was masked to the SVOP results. Based on radi-
ological appearances, and with clinical information includ-
ing full clinical history, VA, ocular motility, optic disc
appearances and results of other VF testing methods, e.g.
confrontation or Goldmann (when available), the panel
predicted an expected visual ﬁeld deﬁcit for each patient.
Additionally, an experienced ophthalmologist (CS),
masked to patient details and imaging, independently
interpreted and described the measured SVOP visual ﬁeld
for each child in the study. Abnormal visual ﬁelds were
those which had two or more contiguous points “unseen” in
the same quadrant or vertical hemiﬁeld, or three or more
non-contiguous “unseen” points in one quadrant or vertical
hemiﬁeld. If a visual ﬁeld was classiﬁed as abnormal, the
defect was categorised using standard neuro-ophthalmology
visual ﬁeld abnormality terms.
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The panel-predicted visual ﬁelds were then compared
with the SVOP results and a two-by-two contingency table
was utilised to determine the sensitivity and speciﬁcity (and
the positive and negative predictive values) of the SVOP
test in detecting a clinically signiﬁcant visual ﬁeld
abnormality.
When children became capable of performing Goldman
visual ﬁeld testing during follow-up, the pattern of visual
ﬁeld abnormality obtained using Goldman testing was
compared with the pattern of visual ﬁeld abnormality
obtained using SVOP. The pair of tests with the shortest
time interval between them was used.
The SVOP technique
The SVOP system comprises a personal computer (PC), a
patient display (20” Liquid Crystal Display, Dell 2005FPW)
and an eye tracker. During the course of this study two
different models of eye tracker (X50 and IS-1 models from
Tobii Technology) were used on different occasions. Fig-
ure 1 demonstrates the hardware.
Prior to any SVOP test, a calibration procedure was
performed, to produce accurate gaze data for the patient
being tested. During a calibration procedure, patients were
required to look at the SVOP display screen and follow a
visual stimulus with their gaze to ﬁve different screen
locations. During this procedure, the eye tracker measures
characteristics of the subject’s eyes (such as pupil position
and shape) and used them together with a mathematical 3D
eye model to calculate gaze position. The calibration sti-
mulus was a cartoon character which moved to each of the
ﬁve screen locations whereupon a simple short animation
was played to hold the attention of the child. The calibration
procedure lasted ~20–30 s.
Each SVOP test began with a central ﬁxation target. For
older children a high contrast circular ﬁxation target was
used while for younger children the ﬁxation target was a
cartoon face to encourage attention and maintain interest.
Fixation targets were of an angular diameter of ~1.5°. Real-
time gaze data allowed the system to identify when the
patient was looking at the ﬁxation target. The instant this
was detected, the ﬁxation target disappeared and a test sti-
mulus was presented at a location in their visual ﬁeld. The
on-screen location and size of the test stimulus was calcu-
lated in real-time and was based on the visual ﬁeld angle to
be tested and the position of the patient’s eyes relative to the
ﬁxation target at that instant. A software algorithm (details
previously published [13]) analysed the direction and
amplitude of any subsequent saccades completed within a
time window of 1 s. If an analysed saccade related to where
the stimulus was shown, this was recorded as a “seen”
stimulus and a new ﬁxation target was presented at the
location of the test stimulus and the process was be repeated
to assess another visual ﬁeld location. Figure 2 shows an
example of three “seen” visual ﬁeld points and the asso-
ciated gaze data used during an SVOP test.
If no gaze response, or an inaccurate saccade, occurred
following the presentation of a visual ﬁeld stimulus, the
point was retested at a later stage in the test. Upon
retesting, if the stimulus was not “seen” it was recorded as
“unseen”. The visual ﬁeld test stimuli were all of size
Goldmann III (0.43° angular diameter) and duration 200
ms. Through the use of a calibrated LCD [14], the lumi-
nance of the test stimuli used and the background was 137
and 10 cd/m2, respectively. For reference, this stimulus
brightness level is equivalent to 14 dB on the scale used by
the Humphrey Field Analyser (HFA). The binocular test
pattern used was a pattern consisting of 40 points (with 10
points in each quadrant) arranged with eccentricity out to
25° (Fig. 2b). The monocular test patterns used were
equivalent to the 40-point (C40) screening test pattern
used on the HFA, with the addition of an extra test point
located at the blind spot.
This study was approved by the Lothian Regional Ethics
Committee. Signed consent was obtained from all partici-
pants and/or their parent or guardian.
Results
Sixteen (seven male, nine female) patients already receiving
treatment and follow-up for brain tumours participated in
this study. The mean age at the time of the reported SVOP
test was 7.2 years (range 2.9–15 years). Patients 4, 8 and 9
were tested using an IS-1 eye tracker while the remaining
thirteen patients were tested using an X50 eye tracker. The
average test time for completed tests was 5 min 4 s (range 1
min 5 s to 9 min 7 s). The large range in test times can be
attributed to the different testing strategies used for younger
and older children and also the size of visual ﬁeld defect
present. Younger children were presented with small car-
toon animations when they successfully detected visual
ﬁeld test stimuli. This animation sequence introduced an
additional 2–3 s per “seen” stimulus. In addition, “unseen”
stimuli are always retested. Consequently, a patient with a
complete hemianopia would have half their visual ﬁeld
points retested, thus lengthening the test time.
The average interval between the SVOP test and the
closest neuroimaging session, used by the consensus panel,
was 52 days (range 5–146 days).
Twelve patients (detailed in Tables 1 and 2) out of six-
teen (75%) successfully performed the SVOP test. SVOP
testing failed due to poor quality eye tracking in four
patients. In two of these patients the eye tracker was unable
to detect the eyes sufﬁciently to perform SVOP testing,
while in the other two patients the eyes were detected but
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the gaze data showed an offset when compared with the
coordinates of the on-screen ﬁxation targets.
In the cases where the eye tracker could not detect the
eyes sufﬁciently, one patient was wearing heavy mascara
and the implications of this was realised subsequent to
testing. The use of mascara is known to be a problem for
eye tracking because it can prevent the accurate detection of
the pupils [15]. This patient was not available for further
testing due to geographical constraints. The second patient
had a diagnosis of neuroﬁbromatosis-1 and had congenital
glaucoma with buphthalmos causing a cloudy cornea in one
eye. The eye tracker was therefore prevented from tracking
the eye due to the opaque nature of the cornea.
In the two patients where poor quality eye tracking was
due to an offset in the gaze data rather than poor detection
of the eyes, one patient had extremely poor VA and
unsteady ﬁxation secondary to marked optic atrophy. The
ﬁnal patient with a failed test had a right hemiplegia with
poor co-ordination and would be expected to have a cor-
responding right hemianopia. However, a reason for the
observed disparity between gaze coordinates and displayed
ﬁxation targets has not been elucidated in this patient.
In each of these four patients, the SVOP system was not
able to determine that the patient was correctly ﬁxating on
the displayed ﬁxation targets (due either to lack of gaze data
or gaze data that did not correspond to the ﬁxation target).
The decision to abort these tests was made by the tester
when it became clear that the test was not proceeding cor-
rectly. This was known because the system would con-
tinually try to regain the child’s ﬁxation and not test any
visual ﬁeld points.
A two-by-two contingency table was used to compare
the gross correlation of ‘normal’ versus ‘abnormal’ visual
ﬁeld between the consensus panel prediction and SVOP
ﬁndings for the twelve successfully completed tests.
(Table 3) There were eight true positives, two true
Fig. 1 The Saccadic Vector
Optokinetic Perimetry (SVOP)
system components. a Patient
display. b Examiner display. c
Eye tracker. d Height adjustable
surface housing the personal
computer
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negatives, and two false positive results. There were no
false negatives. In this series, SVOP therefore had sensi-
tivity for detecting an abnormal visual ﬁeld of 100% and a
speciﬁcity of 50% (positive predictive value of 80% and
negative predictive value of 100%).
Table 1 details the ten cases where panel-predicted visual
ﬁeld were consistent with SVOP results (the eight true
positives are detailed prior to the two true negatives). The
remaining two patients had SVOP results inconsistent with
the panel-predicted visual ﬁeld. Table 2 details these two
false positive results. For further information, including
corresponding neuroimaging and SVOP plots, please see
the online supplementary.doc versions of Tables 1 and 2, at
Eye journal’s website.
Patients 1, 2, 7, 8 and 15 were effectively monocular due
to poor or absent VA in one eye as a result of optic nerve or
chiasmal involvement by tumour. Patients 3, 5, 9 and 14 all
completed monocular and binocular SVOP tests; the test
which best demonstrates the VF abnormality has been
included in the table. Only three of the younger patients (4,
6 and 16) who were unable to comply with monocular
occlusion, had purely binocular SVOP testing.
Six children (1, 2, 3, 14, 15 and 16) became capable of
performing Goldmann Visual Field testing during follow-
up. One had a right hemianopia on Goldmann testing, two
patients had a left hemianopia, one had a right
homonomous hemianopia, and two had a full visual ﬁeld.
The pattern of visual ﬁeld abnormality present on SVOP
testing was the same in every case. Figure 3 compares the
Goldmann ﬁeld results with the SVOP test for the four
children with abnormal ﬁelds conﬁrmed by Goldmann
perimetry.
Discussion
SVOP was successfully performed in the majority (75%) of
this cohort of children with brain tumours, even in those
under three years of age. Successful completion of a test
was associated with 100% sensitivity in detecting a visual
ﬁeld defect when compared with ophthalmic assessment
and/or panel consensus following review of neuroimaging.
In most of these cases the speciﬁc character of the measured
visual ﬁeld defect was compatible with the expected visual
ﬁeld defect when considering the anatomy of the visual
pathways. In case 14, the initial ﬁeld defect detected by the
ﬁrst SVOP differed from the expected defect, despite a
repeatable test. However, a nasal defect detected in that eye
is plausible given that the gliotic scarring in the left tem-
poral lobe is immediately adjacent to the temporal aspect of
the prechiasmal left optic nerve. In this case the panel
prediction was based on a predominantly retrochiasmal
Fig. 2 Example of eye gaze
movements for three different
visual ﬁeld points which were all
“seen” and a normal visual ﬁeld
plot. a Blue lines represent eye
gaze movements made every 20
ms. Red lines represent a change
in ﬁxation (saccade) detected by
SVOP. b A normal visual ﬁeld
plot (with all points “seen”). The
three numbered points
(highlighted with red arrows and
circles) correspond to the
ﬁxation changes numbered in a
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tumour when in fact the area of contact was in the anterior
visual pathway.
Subsequent Goldmann and SVOP testing demonstrated
recovery of a full visual ﬁeld in either eye.
Overall, six children became capable of performing
Goldmann visual ﬁelds testing during follow-up. In each
case, the pattern of visual ﬁeld abnormality was the same
with Goldman testing and SVOP testing. This ﬁnding
supports our contention that SVOP assessment at an early
age in our cohort was reliable. We have previously pub-
lished comparison studies of Humphrey Standard Auto-
mated Perimetry and SVOP in adults, with favourable
results [16].
One of the false positive SVOP tests (case 8) showed
poor quality eye tracking with a prolonged test time (9 min
7 s). A potential loss of interest and concentration from the
child could have resulted in false positive algorithm deci-
sions and scattered unseen points. However, the bilateral
optic tract dysmyelination seen in this patient could have a
measurable effect on the visual ﬁeld. The constricted visual
ﬁeld defect recorded for the remaining false positive case
(case 9), whilst not anticipated by the consensus panel,
could in fact represent a true constriction due to previous
raised intracranial pressure.
Test failure occurred in four children and the reasons
for this have been elucidated. All four of the failures
related to poor eye tracking. In two patients the eye
tracker was unable to detect the eyes sufﬁciently, while
the remaining two patient’s eyes were detected but the
gaze data showed an offset when compared with the
coordinates of the on-screen ﬁxation targets. In each
scenario, the SVOP system was not able to determine that
the patient was correctly ﬁxating on the displayed ﬁxation
targets and hence would not proceed to test visual ﬁeld
points. The decision to abort these tests was made by the
tester when it became clear that the test was not pro-
ceeding in a satisfactory manner.
In patients where eye tracking is poor a complete result is
often not possible. Moreover, it is possible that incomplete
test results should be considered unreliable because of
prolonged test time and reduced interest from the child. InTa
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Table 3 The panel-predicted visual ﬁeld outcome compared with the
SVOP outcome for the twelve successfully performed tests
Visual ﬁeld prediction from imaging (panel
decision)
Abnormal visual ﬁeld Normal visual
ﬁeld
SVOP result
Abnormal visual ﬁeld 8 2
Normal visual ﬁeld 0 2
I. C. Murray et al.
future SVOP studies it will be important to assess the fac-
tors that contribute to unreliable tests so that a useful indi-
cation can be provided to the tester.
In this study, three patients were tested using a different
model eye tracker than the remaining patients. Improve-
ments to eye-tracking technology are continuingly being
Detection and characterisation of visual ﬁeld defects using Saccadic Vector Optokinetic Perimetry in. . .
made and it was thought that a newer model of eye tracker
would improve the SVOP test. Both of the eye trackers used
in this study have since been discontinued by Tobii Tech-
nology due to continuing development of their eye trackers
and our research group have more recently been performing
studies using another eye tracker model (X2-60 also from
Tobii Technology).
There are few reliable alternatives for assessing visual
ﬁeld loss in young children which can show the same level of
detail as SVOP. Manual visual ﬁeld testing approaches, such
as that used by the BEFIE test [11] or the KidzEyes pre-
ferential looking technique [17], have the advantage that they
can obtain visual ﬁeld information for children who cannot
be adequately eye tracked with SVOP. However, they are
unable to accurately test speciﬁc visual ﬁeld locations. The
use of Visual Evoked Potentials (VEPs) for the detection and
monitoring of visual pathway tumours in children has not
shown consistent results [18, 19]. Avery and colleagues have
demonstrated that vision loss in children with visual pathway
gliomas is associated with measurable defects of the retinal
nerve ﬁbre layer (RNFL), as determined by optical coherence
tomography (OCT) [20, 21].
An advantage of SVOP is its ability to characterise the
nature and extent of visual ﬁeld defects, which have important
functional implications for the child and it may be particularly
useful if changes in tumour size or characteristics seen in
neuroimaging are accompanied by functional visual ﬁeld
change detected by SVOP. The automated nature of SVOP
means that minimal experience is required to perform the test
or operate the system. Children ﬁnd the test easy, and as it
takes ~5min to perform. With the use of engaging animations
to hold and maintain concentration, a meaningful test result
was obtained in the majority of cases. In this small cohort
SVOP testing has demonstrated the potential for monitoring
visual ﬁeld changes in young patients with brain tumours in
greater detail than was previously possible.
Future studies using SVOP will focus on longitudinal
follow-up of a cohort of children with visual pathway
tumours to (i) determine the repeatability and reliability of
the test, and (ii) demonstrate changes of visual ﬁeld defects
in relation to progression of tumour size over time, and
response to medical or surgical interventions. For anterior
visual pathway tumours, the use of OCT may be used to
conﬁrm focal deﬁcits in the RNFL corresponding to visual
ﬁeld defects mapped by SVOP.
Summary
What was known before
● Assessment of visual ﬁelds is an important component
of the assessment of visual pathway tumours in
peadiatric neuro-oncology.
● Previous commonly used techniques such as confronta-
tional visual ﬁeld assessment lacked objective detail in
young children, whilst standardised kinetic perimetry
(Goldmann), or automated perimetry, were difﬁcult for
young children to perform reliably.
● Saccadic Vector Optokinetic Perimetry (SVOP) is a
new, objective technique for visual ﬁeld testing designed
for young children.
What this study adds
● We assessed the ability of SVOP to detect expected or
known visual ﬁeld defects in a cohort of sixteen children
with visual pathway tumours.
● SVOP demonstrated 100% sensitivity and 50% speci-
ﬁcity when compared with expected visual ﬁeld
abnormality.
● The diagnosis and management of young children with
visual pathway tumours would be aided by SVOP
testing due to its ability to characterise the central visual
ﬁeld in detail.
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Fig. 3 Children with abnormal visual ﬁelds, who became capable of
Goldman perimetry during follow-up. A comparison of Goldmann and
SVOP visual ﬁelds. a, b Patient 1. Left optic nerve/hypothalamic
pilocytic astrocytoma with blind left eye. Goldman (a) and SVOP (b)
conﬁrm right temporal hemianopia in only seeing eye with residual
right nasal ﬁeld. On the SVOP plot, (○: seen, ●: unseen) c, d Patient
2. Right optic nerve/hypothalamic pilocytic astrocytoma with blind
right eye. Goldman (c) and SVOP (d) conﬁrm left temporal hemi-
anopia in only seeing eye with residual left nasal visual ﬁeld. e, f
Patient 15. Hypothalamic pilocytic astrocytoma with blind right eye.
Goldman (e) and SVOP (f) conﬁrm left temporal hemianopia in seeing
left eye, with residual left nasal ﬁeld of vision. g–i Patient 16. Left
temporal pilocytic astrocytoma. Goldmann (g, h) and binocular SVOP
(i) conﬁrm right-sided hemianopia
I. C. Murray et al.
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